Related Experiment Videos
Prognostic value of procalcitonin in children with meningococcal sepsis
Enitan D Carrol1, Paul Newland, Alistair P J Thomson
1Institute of Child Health, Liverpool Children's Hospital NHS Trust, Alder Hey, Liverpool, UK.
Insights
Procalcitonin is a superior prognostic marker for meningococcal septic shock in children. It accurately predicts septic shock, ventilation needs, and prolonged hospital stays, outperforming lactate and C-reactive protein.
Area of Science:
- Pediatric Infectious Diseases
- Critical Care Medicine
- Biomarker Research
Background:
- Meningococcal sepsis is a life-threatening condition in children.
- Identifying reliable prognostic markers is crucial for timely intervention and improved outcomes.
- Existing markers like lactate and C-reactive protein have limitations in predicting disease severity.
Purpose of the Study:
- To evaluate and compare the prognostic value of procalcitonin, lactate, and C-reactive protein (CRP) in children diagnosed with meningococcal septic shock.
- To determine which biomarker best predicts disease severity, need for mechanical ventilation, and duration of hospital stay.
Main Methods:
- A prospective observational study was conducted.
- The study included children admitted with meningococcal sepsis over a 16-month period.
- Plasma levels of procalcitonin, lactate, and CRP were measured at admission.
Main Results:
- Procalcitonin levels were significantly higher in children with septic shock, those requiring ventilation, and those with prolonged hospital stays (>10 days).
- Procalcitonin and lactate demonstrated strong discriminatory ability for septic shock and prolonged hospital stay (AUCs 0.85-0.87).
- Procalcitonin also effectively predicted the need for ventilation (AUC = 0.72), while CRP showed no significant discriminatory power.
Conclusions:
- Procalcitonin serves as a reliable prognostic marker in pediatric meningococcal sepsis.
- It demonstrates superior performance compared to lactate and C-reactive protein in predicting septic shock, ventilation requirements, and extended hospital stays.
- These findings support the use of procalcitonin for risk stratification in children with meningococcal sepsis.
Objective:
To compare procalcitonin, lactate, and C-reactive protein as prognostic markers in children with meningococcal septic shock.
Design:
Prospective observational study.
Setting:
Alder Hey Children's Hospital, Liverpool, UK.
Patients:
Children admitted to our hospital during a 16-month period with a diagnosis of meningococcal sepsis.
Results:
Plasma procalcitonin at admission was significantly higher in children with septic shock (median, 73.80 vs. 16.44 ng/mL), those requiring ventilation (median, 47.02 vs. 12.00 ng/mL), and those with a duration of hospital stay >10 days (median, 131.35 vs. 19.26 ng/mL). Both procalcitonin and lactate reliably discriminated between those children with septic shock (area under the curve [AUC] = 0.85 and 0.84, respectively) and durations of hospital stay exceeding 10 days (AUC = 0.87 and 0.79, respectively) and those without, but C-reactive protein did not. Procalcitonin alone reliably discriminated between those children requiring ventilation and those who did not (AUC = 0.72).
Conclusion:
Procalcitonin is a reliable prognostic marker of septic shock, requirement for ventilation, and prolonged hospital stay in children with meningococcal sepsis and performs better than lactate and C-reactive protein.
Related Concept Videos
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...
Bacterial Meningitis I: Introduction
Pneumonia III: Complications and Assessment